Chat Place Forum

Forum for general chat. Welcome to chat place forum

It is currently Sat Apr 27, 2024 7:45 pm
---------->CLICK HERE TO CHAT LIVE NOW<----------





Post new topic Reply to topic  [ 1 post ] 
Author Message
 Post subject: Although the experimental results are not as good as expecte
PostPosted: Mon May 09, 2022 4:49 am 
Image


Pfizer Inc. and Biotech SE saidxo walleton Tuesday they had begun filing data with the US regulators. Their vaccine was approved for Emergency Use (EUA) in children under 5 years of age, despite clinical trial results of children 2 to 4 years of age with weaker immune responses than expected.

Both companies revealed that they have begun filing information. After receiving a request from the US Food and Drug Administration (FDA) to address the urgent health needs of this age group.

The FDA said that the advisory committee which consists of external experts will meet on February 15 to consider and approve the petition.

The two companies are asking the FDA to green light their vaccine as a two-dose vaccine, however, Pfizer CEO Albert Burla. stated in the statement that The company believes a third dose of the vaccine will be necessary. "To achieve a high level of protection against various mutants now and in the future"

"If two doses are approved, parents will have the opportunity to begin vaccinating their children with COVID-19 while awaiting approval for the third dose," Burla said.

Both companies are expected to submit complete information. To obtain emergency approval for the 2-dose formulation in the next few days. and then followed by the needle injection data 3.

Pfizer and Biotech The 3 mcg vaccination is being tested in children of this age group. It was downgraded from 10 micrograms for children 5-11 years old and 30 micrograms for children 12 years and older.

in december Pfizer said it is revamping its clinical trials for the three-dose version of the vaccine as a result of the reduced-dose two-dose trial. It was found to induce immune responses in young children aged 2 to 4, less than that in individuals aged 16 to 25.

It is against children aged 6 months to 24 months who produce the same immune response as those aged 16 to 25.

If the FDA and the US Centers for Disease Control and Prevention Approval of Pfizer-BioEntech's request The coronavirus vaccine for young children is expected to be available at the end of February.


Last bumped by Anonymous on Mon May 09, 2022 4:49 am.


Report this post
Top
  
Reply with quote  
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 1 post ] 


Who is online

Users browsing this forum: No registered users and 92 guests


You can post new topics in this forum
You can reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot post attachments in this forum

Jump to:  
Chat Place Privacy
Powered by phpBB © 2000, 2002, 2005, 2007 phpBB Group   
Design By Poker Bandits